West Pharmaceutical Services (WST) Shares Outstanding (2009 - 2026)

West Pharmaceutical Services (WST) has reported Shares Outstanding (Entity) for 18 consecutive years, with $75.3 million the latest figure, recorded in Q2 2026.

• Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $75.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $75.3 million (changed 0.0% YoY) and the FY2025 annual result came in at $75.3 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) was little changed at $75.3 million in Q2 2026 per WST's latest filing, from $75.3 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for WST reached as high as $75.3 million in Q1 2022 and fell as low as $75.3 million in Q1 2022.
• A 5-year average of $75.3 million and a median of $75.3 million in 2022 frame the typical range for Shares Outstanding (Entity).
• The largest YoY upside for Shares Outstanding (Entity) was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
• Year by year, Shares Outstanding (Entity) stood at $75.3 million in 2022, then changed by 0.0% to $75.3 million in 2023, then changed by 0.0% to $75.3 million in 2024, then changed by 0.0% to $75.3 million in 2025, then changed by 0.0% to $75.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $75.3 million, $75.3 million, and $75.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.